Three Original Investigations on the Effect of Telmosartin on Walking Performance in Patients With Peripheral Artery Disease

Telmosartin, an angiotensin receptor blocker, has properties that can reverse the impaired lower extremities skeletal muscle function in patients with peripheral artery disease. The report describes results from a two-by-two factorial design trial that randomized 114 participants between 2015 and 2021. Dr. Mary McDermott sits down with JAMA Deputy Editor Greg Kerfmann to discuss the trial in a related podcast.